Faeth Therapeutics

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

Funding reportedLast round: Series A

BiotechnologySan Francisco, United States

What company datasets say Faeth Therapeutics raised

Funding, as reported

Reported in all$67Min dollars

Rounds4

Last roundSeries A

Last round dateJun 2022

Investors listed9

From Faeth Therapeutics's own website: 3 on the team.

Investors who name them

Each firm lists Faeth Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put Faeth Therapeutics in front of investors. Or tell us what we have wrong.